在阿尔茨海默氏症患者的胆固醇疗法
Serge Gauthier1, Joseph Therriault2, Pedro Rosa-Neto3
1Translational Neuroimaging Laboratory, McGill University Research Center for Studies in Aging, Montreal, QC, Canada; Departments of Neurology and Neurosurgery, Psychiatry, Pharmacology & Therapeutics, McGill University, Montreal, QC, Canada.
胆酶抑制剂已被批准用于阿尔茨海默氏症和其他痴呆症,可提供透皮选择. 未来的治疗可能会针对乙胆通路,以获得更大的益处.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 胆酶抑制剂 (ChIs) 是控制神经退行性疾病的基石.
- 它们的有效性已经通过严格的临床试验来确定.
研究的目的:
- 审查胆酶抑制剂的临床疗效和扩展性指示.
- 讨论给药途径,副作用以及未来的治疗途径.
主要方法:
- 对安慰剂受控随机临床试验的审查.
- 对阿尔茨海默病和其他痴呆症的监管批准进行分析.
- 通过皮肤给予的检查和副交感的副作用.
主要成果:
- 胆酶抑制剂已批准用于阿尔茨海默病,勒维体痴呆症和帕金森病痴呆症的症状治疗.
- 通过皮肤贴片提供了另一种给药途径.
- 周围的副交感刺激是副作用的主要来源.
结论:
- 胆酶抑制剂在各种神经退行性疾病中提供症状益处.
- 对乙胆通路的进一步研究可能会产生额外的治疗优势.
- 通过皮肤输送可以增强痴呆症患者的治疗选择.
更多相关视频
08:01Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
相关概念视频
Alzheimer's Disease: Treatment
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
